A similar mechanism might underlie the tumor growth retardation caused by MAP1B depletion; MAP1B might be required for the trafficking of NMDAR and/or other growth-dependent receptors in breast cancer cells to promote invasive tumor growth in vivo. This evidence concerns the gene MAP1B and neoplasm.